All normal in the quarterly. A few notes
$6.4m cash at bank
$1.06m spend. Higher than normal being spent externally for farmout/ventures
$330k income from JV
$70k in interest
Portfolio has grown to 8 licences, now with minimal work terms expenditure required. Mostly just tech work on some. Equinor are full steam ahead drilling in North Sea so that is a good sign for Boaz.
A nice obscure detail, I count nine prospects in the new licenses (dark green). P2655 is almost entirely un-drilled from memory so I'm interested to know what they see there. It looks like we have a sizeable stranglehold on Buzzard ILX and their production has halved since stage two completed.
"...Whitsun Prospect and progressed discussions with potential partners during the quarter. Whitsun is attracting interest from potential industry partners due to its size and similarity to the nearby Buzzard field." "Progressed discussions" probably translates to 'negotiating terms' in non-corporate speak
Will post more things of note as I continue perusing.
GLTA
OS
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
All normal in the quarterly. A few notes$6.4m cash at bank$1.06m...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FDR (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.1¢ |
Change
0.001(2.00%) |
Mkt cap ! $14.38M |
Open | High | Low | Value | Volume |
5.0¢ | 5.5¢ | 5.0¢ | $47.63K | 929.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 14809 | 5.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.1¢ | 67497 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 14809 | 0.050 |
1 | 20408 | 0.049 |
2 | 620832 | 0.048 |
3 | 430000 | 0.047 |
3 | 453221 | 0.046 |
Price($) | Vol. | No. |
---|---|---|
0.051 | 67497 | 1 |
0.052 | 222191 | 2 |
0.053 | 30000 | 1 |
0.058 | 25000 | 1 |
0.059 | 122222 | 2 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
FDR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online